Celgene keeps M&A pipes flowing in US
GlobalCapital, is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023
Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Corporate BondsHigh grade and crossover bonds

Celgene keeps M&A pipes flowing in US

US biotechnology company Celgene ensured that August got off to a roaring start for high-grade issuance with an $8bn acquisition financing this week.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login